ÂÜÀòÂÒÂ×

Don Daley has held a number of roles in the scientific and technology industries since 1988. Don began their career at Aventis as a Department Struct and Phys Chem before moving to Rhone-Poulenc Rorer in 1995 as a Department Manager Structural and Physical Chemistry. In 2000, they joined Argenta Discovery as a Director DMPK, Physical Sciences and IT. In 2007, they became the Chairperson of BMSS. In 2015, they joined DName-iT as a Non Exec Director and Interim CEO, InClinico International Consulting Ltd as a Managing Director, Frontier Biosciences Ltd as a Chief Technology Officer, and Glythera as a Director Program Management. Finally, in 2019, they joined Oncocidia Ltd. as the Chief Scientific Officer.

Don Daley received their PhD in Structural and Synthetic Studies of Peptides from the University of Cambridge in 2000. Don also attended the University of Cambridge prior to that.